US Patent 8152801 Tissue ablation using pulse modulated radio frequency energy
Patent 8152801 was granted and assigned to Boston Scientific on April, 2012 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8152801 Tissue ablation using pulse modulated radio frequency energy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.